NICE recommends fingolimod on NHS for multiple sclerosis patients
NICE has given the all clear for fingolimod (Gilenya) - a pill that can help adults suffering from highly active relapsing-remitting multiple sclerosis (RRMS).
Get unlimited access
As a subscriber you will benefit from:
- Full online and mobile access to news and opinion stories
- Customised email alerts straight to your inbox (30+ alerts available)
- 4,500 practice articles in our archive
- Over £500 worth of CPD learning units